Urogen Pharma (URGN) Insider Trading & Ownership $19.44 -0.34 (-1.72%) Closing price 04:00 PM EasternExtended Trading$19.25 -0.19 (-1.00%) As of 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Urogen Pharma (NASDAQ:URGN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$621.50K Get URGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Urogen Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address URGN Insider Buying and Selling by Quarter Urogen Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/11/2025Mark SchoenbergInsiderSell10,000$17.69$176,900.00 7/28/2025Jason Drew SmithGeneral CounselSell7,522$19.14$143,971.08 7/28/2025Mark SchoenbergInsiderSell5,149$19.14$98,551.86 6/9/2025Mark SchoenbergInsiderSell5,162$7.37$38,043.94 1/31/2025Jason Drew SmithGeneral CounselSell7,379$11.14$82,202.06 1/31/2025Mark SchoenbergInsiderSell4,551$11.14$50,698.14 9/9/2024Jason Drew SmithGeneral CounselSell1,521$13.08$19,894.68 9/9/2024Mark SchoenbergInsiderSell859$13.08$11,235.72 (Data available from 1/1/2013 forward) URGN Insider Trading Activity - Frequently Asked Questions Who is on Urogen Pharma's Insider Roster? The list of insiders at Urogen Pharma includes Jason Drew Smith, and Mark Schoenberg. Learn more on insiders at URGN. What percentage of Urogen Pharma stock is owned by insiders? 4.70% of Urogen Pharma stock is owned by insiders. Learn more on URGN's insider holdings. Which Urogen Pharma insiders have been selling company stock? The following insiders have sold URGN shares in the last 24 months: Jason Drew Smith ($393,095.64), and Mark Schoenberg ($671,069.76). How much insider selling is happening at Urogen Pharma? Insiders have sold a total of 71,878 Urogen Pharma shares in the last 24 months for a total of $1,064,165.40 sold. Urogen Pharma Key ExecutivesMs. Elizabeth A. Barrett (Age 62)President, CEO & Director Compensation: $1.34MMr. Jason Drew Smith (Age 52)General Counsel, Chief Compliance Officer & Corporate Secretary Compensation: $864.19k1 recent tradesDr. Mark P. Schoenberg M.D. (Age 66)Chief Medical Officer Compensation: $639.83kMr. Dong Kim (Age 46)Chief Financial Officer Compensation: $546.68kVincent I. PerroneSenior Director of Investor RelationsMr. Bryon WornsonExecutive Vice President of Talent, Advocacy & CommunicationsDr. Marina KonortyExecutive Vice President of Research & Development and Technical OperationsMr. Jeffrey Bova M.B.A.Chief Commercial OfficerMr. James Ottinger R.ph.Executive Vice President of Regulatory Affairs & QualityDr. Polly A. Murphy D.V.M. (Age 59)M.B.A., Ph.D., Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies Lantheus Insider Trading MoonLake Immunotherapeutics Insider Trading Protagonist Therapeutics Insider Trading Mirum Pharmaceuticals Insider Trading Apellis Pharmaceuticals Insider Trading Scholar Rock Insider Trading Xenon Pharmaceuticals Insider Trading Amneal Pharmaceuticals Insider Trading NewAmsterdam Pharma Insider Trading Ultragenyx Pharmaceutical Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying This page (NASDAQ:URGN) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Urogen Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Share Urogen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access